China Isotope & Radiation Corp
HKEX:1763
China Isotope & Radiation Corp
Income from Continuing Operations
China Isotope & Radiation Corp
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
China Isotope & Radiation Corp
HKEX:1763
|
Income from Continuing Operations
¥776.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Income from Continuing Operations
¥2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Income from Continuing Operations
¥737.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
19%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Income from Continuing Operations
¥1.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Income from Continuing Operations
¥1.7B
|
CAGR 3-Years
45%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Income from Continuing Operations
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is China Isotope & Radiation Corp's Income from Continuing Operations?
Income from Continuing Operations
776.1m
CNY
Based on the financial report for Dec 31, 2023, China Isotope & Radiation Corp's Income from Continuing Operations amounts to 776.1m CNY.
What is China Isotope & Radiation Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
6%
Over the last year, the Income from Continuing Operations growth was 3%. The average annual Income from Continuing Operations growth rates for China Isotope & Radiation Corp have been 18% over the past three years , 6% over the past five years .